Tessera Defense adds $5M Mandragola convertible credit line at 12%, issues 2.69M shares to lender

BiomX Inc.

New $5,000,000 revolving line of credit from Mandragola Ltd. (Israel) signed Oct. 5, 2026; runs alongside, and does not replace, the prior $2,000,000 May 13, 2026 line.
Advances bear 12% simple interest, mature Oct. 5, 2029, and convert at the lower of the 5-day lowest NYSE American close or $1.00 per share; 19.99% exchange cap pending stockholder approval.
Issued 2,690,500 restricted shares to Mandragola between Sept. 29 and Oct. 2, 2026: 200,000 on conversion of a $95,020 note at $0.4751 per share.
Remaining 2,490,500 shares came in four tranches from cashless exercises of the DFSL warrant issued to Mandragola on April 13, 2026 (60% DFSL stake acquisition).
Company had 8,920,240 shares outstanding as of Oct. 2, 2026 after these issuances and ATM sales; no advances drawn under the new line yet.

This headline and bullets were generated automatically by deepseek-v4.1-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.